Prelude Capital Management’s Hims & Hers Health HIMS Stock Holding History

Prelude Capital Management’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$424K	Buy	+12,240	New	+$329K	0.03%	598
2025 Q2	–	Sell	-14,795	Closed	-$437K	–	1142
2025 Q1	$437K	Sell	14,795 -2,009	-12%	-$74.6K	0.03%	557
2024 Q4	$406K	Buy	16,804 +1,832	+12%	+$45.4K	0.03%	664
2024 Q3	$276K	Buy	14,972 +3,858	+35%	+$69.1K	0.02%	908
2024 Q2	$224K	Sell	11,114 -7,404	-40%	-$123K	0.02%	936
2024 Q1	$286K	Buy	+18,518	New	+$209K	0.02%	919
2021 Q2	–	Sell	-12,542	Closed	-$166K	–	1775
2021 Q1	$166K	Buy	+12,542	New	+$210K	﹤0.01%	1362

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Prelude Capital Management's HIMS Position: Q2 2026 in Review

Prelude Capital Management opened a new position in Hims & Hers Health (HIMS) in Q2 2026: 12,240 shares worth $424K. The stake represents 0.03% of the portfolio and ranks #598 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in HIMS as recently as Q1 2025.

Prelude Capital Management first reported a position in HIMS in Q1 2021 and has held it in 7 quarters since. The position peaked at $437K in Q1 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Prelude Capital Management held 12,240 shares of Hims & Hers Health worth $424K as of Q2 2026.
Hims & Hers Health was a new Prelude Capital Management position in Q2 2026.
Hims & Hers Health made up 0.03% of Prelude Capital Management's portfolio in Q2 2026, its #598 holding.
Prelude Capital Management first reported a position in Hims & Hers Health in Q1 2021 and has held it in 7 quarters since.
Prelude Capital Management's Hims & Hers Health position peaked at $437K in Q1 2025.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.